AVArkadii Vodianyk

Arkadii Vodianyk

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Arkadii Vodianyk has a total of 14 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Observed practices in surgical site infection prevention in Ukraine: national survey results from 2021 and 2025

    by Arkadii Vodianyk, Ievgenii Domin, Jarno Habicht, Taras Baranovskyi, Ana Paula Coutinho Rehse, Miranda Deeves, Artem Horbachevskyi, Ihnat Havrylov, Kateryna Bielka, Sergii Dubrov

  • Open Access

    Efficacy of bacteriophages against Pseudomonas aeruginosa with diverse antibiotic resistance profiles

    by V. A. Poniatovskyi, A. A. Vodianyk, V. P. Shyrobokov, A. V. Kharina

    With the rising prevalence of multidrug-resistant (MDR), extensively drug-resistant (XDR), and pandrug-resistant (PDR) strains of Pseudomonas aeruginosa, the development of alternative therapeutic approaches has become increasingly important. Among these, the use of bacteriophages represents a particularly promising strategy for the treatment of infections caused by multidrug-resistant pathogens. The aim of this study was to isolate and characterize bacteriophages lytically active against P. aeruginosa, to determine their activity spectrum against clinical isolates, and to assess the potential of combining bacteriophages with antibiotics. Materials and methods. The lytic activity of bacteriophages was tested against 23 clinical isolates of P. aeruginosa obtained from pediatric bloodstream infections, including strains carrying antibiotic resistance genes blaNDM-1, blaIMP, blaVIM, and blaTEM. Antimicrobial susceptibility of bacterial isolates was determined using the disk diffusion method according to EUCAST recommendations. Bacteriophages were isolated from wastewater samples collected in Kyiv. Lytic activity was evaluated by the Spot test and a modified agar overlay assay. Morphological characteristics were examined using transmission electron microscopy. Bacteriophage-antibiotic interactions were assessed by a modified disk diffusion method. Results. Between 2021 and 2024, a total of 62 bacteriophages were isolated from wastewater, belonging to the Myoviridae-like, Siphoviridae-like, and Podoviridae-like morphotypes. Their lytic spectra varied considerably, ranging from narrow specificity (2–4 strains) to the ability to lyse more than 20 clinical bacterial isolates. Overall, 29.0 % of bacteriophages showed activity against multiple strains, and some isolates exhibited a broad host range, with specific lysis observed in up to 91.3 % of tested strains. Combination testing revealed a predominantly synergistic interaction between bacteriophages and β-lactam antibiotics, manifested by an increase in both plaque size and number. Conclusions. The isolated bacteriophages demonstrated substantial variability in lytic activity and have potential applications in the treatment of infections caused by multidrug-resistant P. aeruginosa strains. The findings support the feasibility of establishing bacteriophage collections and applying combined bacteriophage-antibiotic therapies. Considering the current epidemiological situation in Ukraine, these results are of practical importance for the development of new antimicrobial strategies.

  • Open Access

    APPLICATION OF BACTERIOPHAGES AGAINST MULTIDRUG-RESISTANT STRAINS OF KLEBSIELLA PNEUMONIAE

    by V.A. Poniatovskyi, V.P Shyrobokov, А.а. Vodianyk, K.L. Rudneva, А.V. Kharina

    Background. The emergence of antimicrobial-resistant microorganisms poses a serious global public health challenge. Klebsiella pneumoniae is among the most common pathogens responsible for healthcare-associated infections, particularly in critically ill patients. The prevalence of multidrug-resistant (MDR) K. pneumoniae has increased dramatically worldwide over recent decades, presenting an urgent threat to public health. In the absence of effective treatments for severe bacterial infections caused by antibiotic-resistant strains, bacteriophages represent a targeted and promising adjunct – and in some cases, an alternative – to conventional therapy. Aim: to explore the possibility of isolating bacteriophages against PDR (pan-drug resistant)/XDR (extensively drug-resistant) strains of K. pneumoniae using urban wastewater samples, and to investigate the spectrum of their activity under in vitro conditions. Materials and Methods. Bacteriophages were isolated using the enrichment method, and their specificity was evaluated using a modified Gratia method and the spot test. Morphological characterization of the isolated phages was performed via electron microscopy. Antimicrobial susceptibility testing was conducted using disk diffusion and broth microdilution methods. Detection of antibiotic resistance genes (blaNDM-1, blaKPC, blaCTX-M-1, and gyrA) was performed by PCR. Results. A total of 212 bacteriophages were isolated from municipal wastewater samples, demonstrating lytic activity against a broad spectrum of clinical isolates and reference strains of K. pneumoniae, including antibiotic-resistant variants. Specifically, 56.1% of the phage isolates showed specific activity against a pre-characterized panel of 15 PDR/XDR K. pneumoniae strains. Notably, each clinical isolate with acquired extensive drug resistance was susceptible to multiple phages, and 14 phages lysed more than 50% of the tested bacterial cultures. The phages exhibited both narrow and broad host ranges, supporting the formulation of effective phage cocktails for potential therapeutic use. Conclusions. The findings demonstrate the high potential of bacteriophages as an alternative or adjunctive strategy in combating multidrug-resistant K. pneumoniae. These experimental results highlight the importance of further development of phage therapy approaches, especially in the context of escalating multidrug-resistant infections.